| Eric Scott Anding, MD | |
|
240 Hospital Pl Ste 202, Soldotna, AK 99669-7559 | |
| (907) 564-2300 | |
| Not Available |
| Full Name | Eric Scott Anding |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 34 Years |
| Location | 240 Hospital Pl Ste 202, Soldotna, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487649521 | NPI | - | NPPES |
| 1477643179 | Other | UT | GROUP NPI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Peninsula General Hospital | Soldotna, AK | Hospital |
| South Peninsula Hospital | Homer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Heart Institute | 2668371469 | 57 |
News Archive
Investigators at Hospital for Special Surgery have identified two new targets for drugs aimed at controlling lupus.
Australian Health Minister Tony Abbott earlier this month approved a plan to develop a genetic profile of HIV in people living with the virus nationwide, Australia's The Age reports.
Trying to break down a barrier that prevents effective treatment of prostate cancer, researchers from The Cancer Institute of New Jersey (CINJ) have identified candidate drugs that block a key protein responsible for tumor growth.
A study found several benefits in using the radial artery in the arm as the entry point for angioplasty or percutaneous coronary intervention (PCI) compared to the femoral artery in the leg. Results of the STEMI-RADIAL trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
› Verified 4 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467547265 PECOS PAC ID: 2163335746 Enrollment ID: O20031110000525 |
News Archive
Investigators at Hospital for Special Surgery have identified two new targets for drugs aimed at controlling lupus.
Australian Health Minister Tony Abbott earlier this month approved a plan to develop a genetic profile of HIV in people living with the virus nationwide, Australia's The Age reports.
Trying to break down a barrier that prevents effective treatment of prostate cancer, researchers from The Cancer Institute of New Jersey (CINJ) have identified candidate drugs that block a key protein responsible for tumor growth.
A study found several benefits in using the radial artery in the arm as the entry point for angioplasty or percutaneous coronary intervention (PCI) compared to the femoral artery in the leg. Results of the STEMI-RADIAL trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
› Verified 4 days ago
| Entity Name | Alaska Heart Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992744114 PECOS PAC ID: 2668371469 Enrollment ID: O20031231000146 |
News Archive
Investigators at Hospital for Special Surgery have identified two new targets for drugs aimed at controlling lupus.
Australian Health Minister Tony Abbott earlier this month approved a plan to develop a genetic profile of HIV in people living with the virus nationwide, Australia's The Age reports.
Trying to break down a barrier that prevents effective treatment of prostate cancer, researchers from The Cancer Institute of New Jersey (CINJ) have identified candidate drugs that block a key protein responsible for tumor growth.
A study found several benefits in using the radial artery in the arm as the entry point for angioplasty or percutaneous coronary intervention (PCI) compared to the femoral artery in the leg. Results of the STEMI-RADIAL trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
› Verified 4 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952430902 PECOS PAC ID: 5799675120 Enrollment ID: O20040318000605 |
News Archive
Investigators at Hospital for Special Surgery have identified two new targets for drugs aimed at controlling lupus.
Australian Health Minister Tony Abbott earlier this month approved a plan to develop a genetic profile of HIV in people living with the virus nationwide, Australia's The Age reports.
Trying to break down a barrier that prevents effective treatment of prostate cancer, researchers from The Cancer Institute of New Jersey (CINJ) have identified candidate drugs that block a key protein responsible for tumor growth.
A study found several benefits in using the radial artery in the arm as the entry point for angioplasty or percutaneous coronary intervention (PCI) compared to the femoral artery in the leg. Results of the STEMI-RADIAL trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Scott Anding, MD 3841 Piper St Ste T100, Anchorage, AK 99508-4674 Ph: (907) 561-3211 | Eric Scott Anding, MD 240 Hospital Pl Ste 202, Soldotna, AK 99669-7559 Ph: (907) 564-2300 |
News Archive
Investigators at Hospital for Special Surgery have identified two new targets for drugs aimed at controlling lupus.
Australian Health Minister Tony Abbott earlier this month approved a plan to develop a genetic profile of HIV in people living with the virus nationwide, Australia's The Age reports.
Trying to break down a barrier that prevents effective treatment of prostate cancer, researchers from The Cancer Institute of New Jersey (CINJ) have identified candidate drugs that block a key protein responsible for tumor growth.
A study found several benefits in using the radial artery in the arm as the entry point for angioplasty or percutaneous coronary intervention (PCI) compared to the femoral artery in the leg. Results of the STEMI-RADIAL trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
› Verified 4 days ago
Kristin Mildred Mitchell, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 247 N Fireweed, Ste A Peninsula Internal Medicine Pc, Soldotna, AK 99669 Phone: 907-262-8597 Fax: 907-262-6516 | |
Eileen Karen Sverdrup, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 43977 Sterling Hwy, Ste G, Soldotna, AK 99669 Phone: 907-262-7201 Fax: 907-260-5392 | |
Dr. Musaberk Goksel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 240 Hospital Pl, Soldotna, AK 99669 Phone: 907-714-4529 Fax: 907-714-4916 | |
Dr. Megan Roosen-runge, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 247 N Fireweed St Ste A, Soldotna, AK 99669 Phone: 907-262-8597 Fax: 907-262-6516 | |
Bill Hoon Kim, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 240 Hospital Pl Ste 103b, Soldotna, AK 99669 Phone: 907-714-6120 Fax: 907-416-7683 | |
John Paul Bramante, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 247 N Fireweed, Suite A, Soldotna, AK 99669 Phone: 907-262-8597 Fax: 907-262-6516 | |
Dr. Tricia Button Elliott Mcdonagh, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 247 N Fireweed St, Suite A, Soldotna, AK 99669 Phone: 907-262-8597 Fax: 907-262-6516 |